Salvador Aznar expects great advances in immunotherapy against cancer in 2018

Salvador Aznar Benitah, head of the IRB Barcelona group "Stem Cells and Cancer". (Photo: Battista-Minocri, IRB)

Salvador Aznar Benitah, head of the IRB Barcelona group "Stem Cells and Cancer". (Photo: Battista-Minocri, IRB)


ARA newspaper has published an article about the topics that are likely to have greatest relevance in the field of science during 2018. The article includes a quote from Salvador Aznar, group leader of the Stem Cell and Cancer Laboratory at IRB Barcelona, who says that there will be advances in approaches to stimulate the immune system to fight against the development of tumors.

Link to Ara